Oncotype DX Genomic Prostate Score® (GPSTM) Test

Testing Process

Effective August 2, 2022, mdxhealth has acquired the Oncotype DX Genomic Prostate Score (GPS) test from Exact Sciences. Additionally, Exact Sciences will continue to perform the GPS test during the transition. For more details, please review the press release.
Questions? Email: gps@mdxhealth.com

The Genomic Prostate Score® (GPS) test is performed on a small tissue sample that’s already been taken from your most recent biopsy. Once the sample has arrived at the Exact Sciences lab,* the GPS test measures the activity of the group of cancer-related genes that are in your tumor tissue. The activity of these genes can provide important information about how your specific cancer might behave in the future, including:

  • Your level of risk for prostate cancer death
  • How likely your cancer is to metastasize with 10 years after surgery
  • Your risk for adverse pathology

 

Graph Low vs High risk patients

 

 

Has your doctor ordered GPS testing for you?

This short video can help you understand how the results gave prostate cancer patient Dan the confidence to delay his treatment.

Talking to your doctor about the GPS test

Like other lab tests, the GPS test must be ordered by a licensed healthcare provider (like your doctor). Whether you decide to get the test or not, you’ll certainly have a lot to talk with your doctor about.

Here are some questions you may want to ask:

  • I understand that my prostate cancer is early stage and localized. What are my treatment options? What do you suggest for me and why?
  • What are the benefits of each treatment option? What are the drawbacks/side effects of each one?
  • How long do side effects of each treatment option last? Do they go away once treatment is complete?
  • Is it okay to wait a few weeks to consider my treatment plan options before I have to make a decision about treatment?
  • What are the chances of my cancer coming back if I choose to have surgery?
  • What are the chances of my cancer coming back if I choose to have radiation?
  • Am I a candidate for the Genomic Prostate Score (GPS) test?
  • What is a Gleason score?
  • If I am a candidate for the GPS test, how could we use the test results to develop my treatment plan?
  • How can I get a copy of my pathology report and my GPS test results (if I’m eligible for the test)?

Learn how the GPS test helps individualize your treatment

What you can expect from the GPS test results

In their own words: Stories from patients with early-stage prostate cancer

See FAQs and videos about the GPS test

89%
of GPS test patients have $0 financial responsibility

This calculation includes patients with Medicare, Medicare Advantage, Medicaid, Managed Medicaid, and commercial insurance. Your cost-sharing amounts, including deductibles and copays, will vary by plan and coverage type. Only your insurer can confirm if and how the GPS test will be covered.

94%
of GPS test patients have a financial responsibility of <$100

This calculation includes patients with Medicare, Medicare Advantage, Medicaid, Managed Medicaid, and commercial insurance. Patients with high-deductible plans may receive a bill for most or all of the cost of the GPS test if they have not satisfied their deductible.

Learn about costs, coverage, and how Exact Sciences can help

 

 

*Testing performed at an Exact Sciences clinical lab in Redwood City, CA (Genomic Health, Inc.).
†The numbers cited are based on historical patient billing data from 1/02/2021 to 12/31/2021. Rates of coverage vary by state and region. Exceptions for coverage may apply. Exact Sciences strongly encourages patients to contact their insurer with questions about the GPS test coverage.